CD44 and gastric cancer: In our study, results of tissue microarray analysis of GC patients showed that negative RP-1 staining was more associated with good prognosis compared with anti-CD44 monoclonal antibody staining, and positivity of both RP-1 and anti-CD44 antibody were comparably associated with poor prognosis.